SandozSenior Manager, Marketing
Mar. 2022 - Mar. 2025Makati, National Capital Region, PhilippinesManaged the Anti-Infectives franchise, including Zinnat, Zinacef, Fortum, Azyth, and Mycamine. Developed and executed strategic marketing plans to drive brand growth and market performance. - Surpassed the 2024 launch target of Mycamine, achieving 124% attainment by building a high-performing medrep/key account hybrid team and executing a targeted launch campaign tailored for infectious disease specialists.
- Accelerated sellout growth of the Anti-Infectives franchise by 22%, spearheaded by flagship brands Zinnat and Zinacef, culminating in a 38% cumulative increase in 2023. - Recovered and surpassed pre-pandemic market share for Zinnat and Zinacef, increasing from 22% to 25% in 2022 through strategic market re-engagement and competitive positioning.
- Boosted Zinnat and Zinacef prescriptions by 40% in 2022 by optimizing primary care engagement and targeting high-potential specialties based on relevant indications.
- Led multi-franchise CME campaigns for primary care physicians across GMA and regional chapters, achieving over 100 high-impact touchpoints per execution.